3-bromo-5-ethyl-1,2,4-oxadiazole(SALTDATA: FREE)
|
|
3-bromo-5-ethyl-1,2,4-oxadiazole(SALTDATA: FREE) Eigenschaften
- Siedepunkt:
- 221.1±23.0 °C(Predicted)
- Dichte
- 1.643±0.06 g/cm3(Predicted)
- storage temp.
- -20°C, sealed storage, away from moisture
- pka
- -4.05±0.20(Predicted)
- Aussehen
- Colorless to off-white Liquid
Sicherheit
3-bromo-5-ethyl-1,2,4-oxadiazole(SALTDATA: FREE) Chemische Eigenschaften,Einsatz,Produktion Methoden
3-bromo-5-ethyl-1,2,4-oxadiazole(SALTDATA: FREE) Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
3-bromo-5-ethyl-1,2,4-oxadiazole(SALTDATA: FREE) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 11)Lieferanten
| Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
|---|---|---|---|---|---|
| Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 |
sales@molcore.com | China | 49734 | 58 |
| J & K SCIENTIFIC LTD. | 18210857532; 18210857532 |
jkinfo@jkchemical.com | China | 96815 | 76 |
| Aikon International Limited | 025-58851090 13913916777 |
sales01@aikonchem.com | China | 15949 | 58 |
| Shanghai Haohong Pharmaceutical Co., Ltd. | 400-8210725 4008210725 |
malulu@leyan.com | China | 54995 | 58 |
| Nanjing Shizhou Biology Technology Co.,Ltd | 025-025-85560043 17301488900 |
info@synzest.com | China | 9286 | 58 |
| Andxi Pharm Co., Ltd. | 19951207836 |
3119034156@qq.com | China | 490 | 58 |
| Bide Pharmatech Ltd. | 400-1647117 13681763483 |
product02@bidepharm.com | China | 59936 | 58 |
| Nanjing Hongwang Pharmaceutical Technology Co., Ltd | 15366073145 |
3016wan@163.com | China | 897 | 58 |
| Changzhou Yourui Pharmaceutical Technology Co., Ltd | 18168818882 15961169601; |
877458914@qq.com | China | 8710 | 58 |
| Shijiazhuang Yansheng Biotechnology Co., LTD | 18332018567; 18332018567 |
331860441@qq.com | China | 3001 | 58 |
- 3-bromo-5-ethyl-1,2,4-oxadiazole(SALTDATA: FREE)
- 1,2,4-Oxadiazole, 3-bromo-5-ethyl-
- 3-bromo-5-ethyl-1,2,4-oxadiazole(SALTDATA
- 3-bromo-5-ethyl-1,2,4-oxadiazole
- 1256643-25-0




